OBJECTIVES: Pre-antiretroviral therapy (ART) HIV-related survival and timing of HIV identification have not been reported from the Caribbean. Using Jamaican national surveillance data, we estimated overall, AIDS-free, and AIDS survival, identified factors influencing HIV-related mortality, and examined factors associated with late HIV/AIDS identification. METHODS: The Jamaican HIV/AIDS tracking system (HATS) national surveillance data included timing of first positive HIV test, stage at identification, date of AIDS diagnosis, and death. We estimated overall and AIDS-free survival by initial stage, using a proportional hazard model to identify factors associated with worse survival, and logistic regression to examine factors related to later case identification. RESULTS: Of 10674 reported HIV cases, 48% were asymptomatic, 14% symptomatic, and 38% first reported with AIDS. Five-year AIDS-free survival was 77% for asymptomatic persons and 63% for symptomatic. Median survival after AIDS diagnosis was 1.02 years. Age, number of opportunistic diseases, and initial stage were strongly associated with mortality. Older age, drug use, and sex with a commercial sex worker were associated with later identification. CONCLUSIONS: In the pre-ART era, over one-third of HIV-infected persons in Jamaica were first identified with advanced disease. This highlights the need for earlier diagnosis as ART programs roll out in the Caribbean.
OBJECTIVES: Pre-antiretroviral therapy (ART) HIV-related survival and timing of HIV identification have not been reported from the Caribbean. Using Jamaican national surveillance data, we estimated overall, AIDS-free, and AIDS survival, identified factors influencing HIV-related mortality, and examined factors associated with late HIV/AIDS identification. METHODS: The Jamaican HIV/AIDS tracking system (HATS) national surveillance data included timing of first positive HIV test, stage at identification, date of AIDS diagnosis, and death. We estimated overall and AIDS-free survival by initial stage, using a proportional hazard model to identify factors associated with worse survival, and logistic regression to examine factors related to later case identification. RESULTS: Of 10674 reported HIV cases, 48% were asymptomatic, 14% symptomatic, and 38% first reported with AIDS. Five-year AIDS-free survival was 77% for asymptomatic persons and 63% for symptomatic. Median survival after AIDS diagnosis was 1.02 years. Age, number of opportunistic diseases, and initial stage were strongly associated with mortality. Older age, drug use, and sex with a commercial sex worker were associated with later identification. CONCLUSIONS: In the pre-ART era, over one-third of HIV-infectedpersons in Jamaica were first identified with advanced disease. This highlights the need for earlier diagnosis as ART programs roll out in the Caribbean.
Authors: N K Sewankambo; R H Gray; S Ahmad; D Serwadda; F Wabwire-Mangen; F Nalugoda; N Kiwanuka; T Lutalo; G Kigozi; C Li; M P Meehan; H Brahmbatt; M J Wawer Journal: AIDS Date: 2000-10-20 Impact factor: 4.177
Authors: Jonathan Mermin; John Lule; John Paul Ekwaru; Samuel Malamba; Robert Downing; Ray Ransom; Frank Kaharuza; David Culver; Francis Kizito; Rebecca Bunnell; Aminah Kigozi; Damalie Nakanjako; Winnie Wafula; Robert Quick Journal: Lancet Date: 2004 Oct 16-22 Impact factor: 79.321
Authors: Shabbar Jaffar; Alison D Grant; Jimmy Whitworth; Peter G Smith; Hilton Whittle Journal: Bull World Health Organ Date: 2004-06 Impact factor: 9.408
Authors: N Kumarasamy; Suniti Solomon; Timothy P Flanigan; R Hemalatha; S P Thyagarajan; Kenneth H Mayer Journal: Clin Infect Dis Date: 2002-12-09 Impact factor: 9.079
Authors: Dawn K Smith; Lytt I Gardner; Ruby Phelps; Merle E Hamburger; Charles Carpenter; Robert S Klein; Ann Rompalo; Paula Schuman; Scott D Holmberg Journal: J Urban Health Date: 2003-12 Impact factor: 3.671
Authors: Andrew M Abaasa; Jim Todd; Kenneth Ekoru; Joan N Kalyango; Jonathan Levin; Emmanuel Odeke; Charles A S Karamagi Journal: BMC Health Serv Res Date: 2008-11-20 Impact factor: 2.655
Authors: Ben Masiira; Kathy Baisley; Billy N Mayanja; Patrick Kazooba; Dermot Maher; Pontiano Kaleebu Journal: Glob Health Action Date: 2014-01-15 Impact factor: 2.640
Authors: Stefan Tenzer; Hayley Crawford; Phillip Pymm; Robert Gifford; Vattipally B Sreenu; Mirjana Weimershaus; Tulio de Oliveira; Anne Burgevin; Jan Gerstoft; Nadja Akkad; Daniel Lunn; Lars Fugger; John Bell; Hansjörg Schild; Peter van Endert; Astrid K N Iversen Journal: Cell Rep Date: 2014-04-13 Impact factor: 9.423